The vaccine was authorized as a primary immunization series for adults, rather than a booster, which may limit its market at first.
- healthupfoundation@gmail.com
- +1 216.832.7936
The vaccine was authorized as a primary immunization series for adults, rather than a booster, which may limit its market at first.